Ty Simpson is the CAR-T CNC for clinical trials at the Alfred Hospital in Melbourne. He coordinates care for clinical trial patients from the early stages of pre-screening, acute inpatient admission through to long term follow-up. Ty manages patients with a variety of haematological malignancies receiving novel CAR-T therapies. He will also oversee the introduction of NK-CAR cells for solid tumour in medical oncology. Ty began his career working in ICU as a cardio-pulmonary transplantation nurse in Sydney, before following his passion in haematology. Ty’s other interests include patient experience, improving patient outcomes and holistic care.

Belinda Lambros is the Nurse Practitioner for Infectious Diseases and Antimicrobial Stewardship in Oncology at the Peter MacCallum Cancer Centre in Melbourne and a Clinician researcher with the National Centre for Infections in Cancer and Transplantation. I have a passion for improving patient outcomes, patient and staff education, and making systems and digital tools work efficiently to allow bedside staff to be able to provide optimal evidence based care. My current role is the first of its kind in Australia and provides support for PeterMac patients in both the inpatient and ambulatory settings. The key areas of the role include: Sepsis Pathway, Antibiotic Allergy assessment and de-labelling, Low Risk Febrile Neutropenia ambulatory program, Antimicrobial Stewardship, Vaccination for cancer patients and education to clinical staff on these areas. I am currently also undertaking a Digital Health Fellowship with the University of Melbourne focusing on Sepsis pathways in the EMR. With over 15 years previous nursing experience and a Masters in Advanced Nursing Practice, I bring knowledge from working in various areas such as critical care, cancer experiences research and tumour stream specialist nursing.

Dr Smibert is the lead for transplant infectious diseases at Austin Health and PhD student at the Peter Mac Callum Cancer Center and University of Melbourne. In 2019 she completed a fellowship at Massachusetts General Hospital, Harvard University in transplant infectious diseases. She has earned a number of awards including the 2019 NHMRC Gustav Nossal Postgraduate Scholarship Award, an International Investigator Award from the Infectious Diseases Society of America, an American Society of Transplant Fellows Award, and the RACP Richard Kemp Memorial Fellowship. She has contributed to over 49 peer-reviewed publications and is undertaking her PhD at the Peter MacCallum Cancer Centre through the Department of Oncology. Her PhD project aims to define the role of the microbiome in determining infectious and immunological outcomes in immune-compromised specialty patient populations and how this could lead to novel therapeutics and diagnostics.